Journal profile · MEDICINE, GENERAL & INTERNAL
Acta Clinica Belgica
ISSN 1784-3286 · eISSN 2295-3337 · Taylor and Francis Ltd. · ENGLAND
Acta Clinica Belgica: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 1.55; JCR Q2 (journal website); subscription journal; APC about USD 2,490; median 87 days to acceptance (96 articles, last 24 months); acceptance rate 12% (journal website); 38 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Acta Clinica Belgica is published by Taylor and Francis Ltd. and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Streptococcal Infections and Treatments, Infective Endocarditis Diagnosis and Management and Venous Thromboembolism Diagnosis and Management, together about 14.9% of its articles. Its main subfields are Epidemiology. (generated from OpenAlex topic counts and CAS ranking data)
Acta Clinica Belgica: International Journal of Clinical and Laboratory Medicine primarily publishes papers on clinical medicine, microbiology, clinical chemistry and molecular biology - provided they describe results which contribute to our understanding of clinical problems, or describe new methods applicable to clinical investigation. Although international, the journal has a particular interest in submissions relevant to Belgian healthcare. The journal is characterized by the rapid reporting of reviews, original research, and clinical studies across all disease areas. Readership includes physicians and pharmacists working in non-academic and academic hospitals, practicing internal medicine and its subspecialties and laboratory medicine. Specific topics covered by the journal include: Diagnosis and nonsurgical treatment of diseases Elucidation of disease processes and management protocols Development of new healthcare programs and optimizing clinical outcomes Improved patient outcomes Monitoring and treatment protocols Multi-system disease processes Prevention Pathogenesis Epidemiology Clinical chemistry Molecular biology All submitted manuscripts are subject to an initial appraisal by the Editor and, if found suitable for further consideration, all research articles will be submitted to peer review by independent, anonymous expert referees. Letters and Editorials will be internally reviewed by the Editors or sent for peer review at the Editor's discretion. All peer review is single anonymized and submission is online via ScholarOne. The journal does not consider animal studies. The priority for case reports is low.
From the journal's Aims & Scope
Research area (LetPub): MEDICINE, GENERAL & INTERNAL
Editor-in-chief Marijn SpeeckaertPublisher website
Editorial board by country: none in mainland China; most named Belgium 31 (31 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Streptococcal Infections and TreatmentsMedicine5.2%
- Infective Endocarditis Diagnosis and ManagementMedicine4.9%
- Venous Thromboembolism Diagnosis and ManagementMedicine4.8%
- Pituitary Gland Disorders and TreatmentsMedicine4.7%
- Infectious Diseases and TuberculosisMedicine4.4%
- Antibiotics Pharmacokinetics and EfficacyMedicine4.1%
- Sarcoidosis and Beryllium Toxicity ResearchMedicine4.1%
- Pneumonia and Respiratory InfectionsMedicine4.1%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Medicine, General & Internal | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Medicine, General & Internal | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Medicine, General & Internal | Zone 4 |
Top journal: noReview journal: no
JCR / CiteScore quartiles on the journal's website
- JCR Q2 · best quartile · 2025
- CiteScore Q1 · 2025
Publisher-reported: JCR figures are Clarivate's and CiteScore figures Scopus's to confirm; both are a different system from the CAS zones.Publisher website
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEPubMedEmbaseCurrent ContentsPublisher website
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 1.55LetPub ·
- Impact factor (publisher) 2025
- 1.4Publisher website ·
- 5-year impact factor (publisher) 2025
- 1.3Publisher website ·
- CiteScore 2026-06
- 3.6LetPub ·
- CiteScore (publisher) 2025
- 3.6Publisher website ·
- SJR 2026-06
- 0.41LetPub ·
- SJR (publisher) 2025
- 0.41Publisher website ·
- SNIP 2026-06
- 0.53LetPub ·
- SNIP (publisher) 2025
- 0.53Publisher website ·
- h-index
- 33LetPub ·
- h-index
- 53OpenAlex ·
- i10-index
- 789OpenAlex ·
- 2-year mean citedness
- 1.22OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 1.74%LetPub ·
Volume
- Articles per year
- 51LetPub ·
- Downloads per year (publisher)
- 53,000Publisher website ·
- Downloads per year (publisher) 2024
- 53,000Publisher website ·
Articles by year OpenAlex count · 5,161 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 57 | 13 | 20 |
| 2025 | 38 | 9 | 33 |
| 2024 | 48 | 13 | 122 |
| 2023 | 36 | 15 | 140 |
| 2022 | 51 | 16 | 189 |
| 2021 | 88 | 35 | 564 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
87 daysMedian, submission to acceptance · P25–P75 59 days – 113 days
- Acceptance to online
- median 16 days (96 articles)
- Submission to online
- median 104 days
- Sample
- 96 articles with submission and acceptance dates (103 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Acceptance rate (publisher)
- 12%Publisher website ·
- Acceptance rate (publisher) 2024
- 12%Publisher website ·
- Submission to first decision
- 8 daysPublisher website ·
- Submission to first decision 2024
- 8 daysPublisher website ·
- First decision after review
- 37 daysPublisher website ·
- First decision after review 2024
- 37 daysPublisher website ·
- Acceptance to publication
- 19 daysPublisher website ·
- Acceptance to publication 2024
- 19 daysPublisher website ·
- Peer review
- Single anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Subscription journalLetPub
A subscription journal: articles are read by subscription or purchase, and authors usually pay no publication charge.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| Publisher website | USD 2,490 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare1 items from the author guidelines
- Not considered
- animal studies; case reports
Policy excerpts from the journal's websiteAI use, Open access, Peer review
- AI use Effective prompt design for large language models in clinical practice
Steven Callens Review Article | Published online: 12 Jan 2026
Source ↗Publisher website ·- Open access Open access
Acta Clinica Belgica is a hybrid open access journal that is part of the Taylor & Francis Open Select publishing program, giving you the option to publish open access. Publishing open access means that your article will be free to access online immediately on publication, increasing the visibility, readership, and impact of your research. Why choose open access? Increase the discoverability and re…
Source ↗Publisher website ·- Peer review
Peer review is single anonymized; submission via ScholarOne. Model summary
All peer review is single anonymized and submission is online via ScholarOne.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Taylor and Francis Ltd.
- Country or region
- ENGLAND
- Language
- English
- ISSN
- 1784-3286
- Electronic ISSN
- 2295-3337
- Society / sponsor
- BSIM and RBSLM
- Latest issue on the website
- Volume 81, Issue 5 (2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Acta Clinica Belgica
What CAS zone is Acta Clinica Belgica in?
In the 2025 upgraded edition of the CAS Journal Ranking, Acta Clinica Belgica is in Zone 4 of Medicine, and in Zone 4 of the minor category Medicine, General & Internal. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Acta Clinica Belgica?
The latest impact factor listed by LetPub is 1.55; CiteScore 3.6, h-index 53.
How long does peer review take at Acta Clinica Belgica?
Based on the dates recorded on 96 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 87 days (interquartile range 59–113 days); the journal's website gives an acceptance rate of 12% (2024). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What JCR quartile is Acta Clinica Belgica in?
The journal's website gives JCR Q2 (best quartile). JCR quartiles are Clarivate's to confirm and a different system from the CAS zones; in the CAS ranking the journal is in Zone 4 of Medicine.
Where are the editorial board members of Acta Clinica Belgica based?
Of the 31 board members whose country the journal's board page names, none are in mainland China; the countries named most often are Belgium (31). Counted from the institutions listed on the board page; for reference only.
Which databases index Acta Clinica Belgica?
According to LetPub and DOAJ records, Acta Clinica Belgica is indexed in SCIE and Scopus. The journal's website also lists MEDLINE, PubMed, Embase and Current Contents; that list has not been checked against each database.
Is Acta Clinica Belgica open access, and what is the APC?
Acta Clinica Belgica is a subscription journal. APC about USD 2,490.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .